Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma.

Thomsen MK, Skouboe MK, Boularan C, Vernejoul F, Lioux T, Leknes SL, Berthelsen MF, Riedel M, Cai H, Joseph JV, Perouzel E, Tiraby M, Vendelbo MH, Paludan SR.

Oncogene. 2019 Nov 18. doi: 10.1038/s41388-019-1108-8. [Epub ahead of print]

PMID:
31740782
2.

A 35-Year-Old Woman With Acute Pleuritic Chest Pain and an Unusual Mediastinal Opacity.

Simon C, Lorek C, Boularan C, Fontaine-Delaruelle C.

Chest. 2019 Jan;155(1):e17-e20. doi: 10.1016/j.chest.2018.07.036.

PMID:
30616743
3.

i Signaling Promotes Marginal Zone B Cell Development by Enabling Transitional B Cell ADAM10 Expression.

Hwang IY, Boularan C, Harrison K, Kehrl JH.

Front Immunol. 2018 Apr 11;9:687. doi: 10.3389/fimmu.2018.00687. eCollection 2018.

4.

STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice.

Skouboe MK, Knudsen A, Reinert LS, Boularan C, Lioux T, Perouzel E, Thomsen MK, Paludan SR.

PLoS Pathog. 2018 Apr 2;14(4):e1006976. doi: 10.1371/journal.ppat.1006976. eCollection 2018 Apr.

5.

Design, Synthesis, and Biological Evaluation of Novel Cyclic Adenosine-Inosine Monophosphate (cAIMP) Analogs That Activate Stimulator of Interferon Genes (STING).

Lioux T, Mauny MA, Lamoureux A, Bascoul N, Hays M, Vernejoul F, Baudru AS, Boularan C, Lopes-Vicente J, Qushair G, Tiraby G.

J Med Chem. 2016 Nov 23;59(22):10253-10267. Epub 2016 Nov 4.

PMID:
27783523
6.

Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.

Galandrin S, Denis C, Boularan C, Marie J, M'Kadmi C, Pilette C, Dubroca C, Nicaise Y, Seguelas MH, N'Guyen D, Banères JL, Pathak A, Sénard JM, Galés C.

Hypertension. 2016 Dec;68(6):1365-1374. Epub 2016 Oct 3.

PMID:
27698068
7.

Glycosylation-Dependent IFN-γR Partitioning in Lipid and Actin Nanodomains Is Critical for JAK Activation.

Blouin CM, Hamon Y, Gonnord P, Boularan C, Kagan J, Viaris de Lesegno C, Ruez R, Mailfert S, Bertaux N, Loew D, Wunder C, Johannes L, Vogt G, Contreras FX, Marguet D, Casanova JL, Galès C, He HT, Lamaze C.

Cell. 2016 Aug 11;166(4):920-934. doi: 10.1016/j.cell.2016.07.003. Epub 2016 Aug 4.

8.

Analysis of Arrestin Recruitment to Chemokine Receptors by Bioluminescence Resonance Energy Transfer.

Bonneterre J, Montpas N, Boularan C, Galés C, Heveker N.

Methods Enzymol. 2016;570:131-53. doi: 10.1016/bs.mie.2015.09.003. Epub 2015 Nov 29.

PMID:
26921945
9.

Cardiac cAMP: production, hydrolysis, modulation and detection.

Boularan C, Gales C.

Front Pharmacol. 2015 Oct 1;6:203. doi: 10.3389/fphar.2015.00203. eCollection 2015. Review.

10.

Focal nodular hyperplasia and hepatocellular adenoma: The value of shear wave elastography for differential diagnosis.

Brunel T, Guibal A, Boularan C, Ducerf C, Mabrut JY, Bancel B, Boussel L, Rode A.

Eur J Radiol. 2015 Nov;84(11):2059-64. doi: 10.1016/j.ejrad.2015.07.029. Epub 2015 Aug 3.

PMID:
26299323
11.

B Lymphocyte-Specific Loss of Ric-8A Results in a Gα Protein Deficit and Severe Humoral Immunodeficiency.

Boularan C, Hwang IY, Kamenyeva O, Park C, Harrison K, Huang Z, Kehrl JH.

J Immunol. 2015 Sep 1;195(5):2090-102. doi: 10.4049/jimmunol.1500523. Epub 2015 Jul 31.

12.

Neutrophil recruitment to lymph nodes limits local humoral response to Staphylococcus aureus.

Kamenyeva O, Boularan C, Kabat J, Cheung GY, Cicala C, Yeh AJ, Chan JL, Periasamy S, Otto M, Kehrl JH.

PLoS Pathog. 2015 Apr 17;11(4):e1004827. doi: 10.1371/journal.ppat.1004827. eCollection 2015 Apr.

13.

Dual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signaling.

Bellot M, Galandrin S, Boularan C, Matthies HJ, Despas F, Denis C, Javitch J, Mazères S, Sanni SJ, Pons V, Seguelas MH, Hansen JL, Pathak A, Galli A, Sénard JM, Galés C.

Nat Chem Biol. 2015 Apr;11(4):271-9. doi: 10.1038/nchembio.1766. Epub 2015 Feb 23.

14.

An essential role for RGS protein/Gαi2 interactions in B lymphocyte-directed cell migration and trafficking.

Hwang IY, Park C, Harrison K, Boularan C, Galés C, Kehrl JH.

J Immunol. 2015 Mar 1;194(5):2128-39. doi: 10.4049/jimmunol.1401952. Epub 2015 Jan 23.

15.

Canonical and noncanonical g-protein signaling helps coordinate actin dynamics to promote macrophage phagocytosis of zymosan.

Huang NN, Becker S, Boularan C, Kamenyeva O, Vural A, Hwang IY, Shi CS, Kehrl JH.

Mol Cell Biol. 2014 Nov 15;34(22):4186-99. doi: 10.1128/MCB.00325-14. Epub 2014 Sep 15.

16.

SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome.

Shi CS, Qi HY, Boularan C, Huang NN, Abu-Asab M, Shelhamer JH, Kehrl JH.

J Immunol. 2014 Sep 15;193(6):3080-9. doi: 10.4049/jimmunol.1303196. Epub 2014 Aug 18.

17.

A biosensor to monitor dynamic regulation and function of tumour suppressor PTEN in living cells.

Lima-Fernandes E, Misticone S, Boularan C, Paradis JS, Enslen H, Roux PP, Bouvier M, Baillie GS, Marullo S, Scott MG.

Nat Commun. 2014 Jul 16;5:4431. doi: 10.1038/ncomms5431.

PMID:
25028204
18.

Omega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-κB activation and enhancing autophagy.

Williams-Bey Y, Boularan C, Vural A, Huang NN, Hwang IY, Shan-Shi C, Kehrl JH.

PLoS One. 2014 Jun 9;9(6):e97957. doi: 10.1371/journal.pone.0097957. eCollection 2014.

19.

Implications of non-canonical G-protein signaling for the immune system.

Boularan C, Kehrl JH.

Cell Signal. 2014 Jun;26(6):1269-82. doi: 10.1016/j.cellsig.2014.02.010. Epub 2014 Feb 28. Review.

20.

Resistance to inhibitors of cholinesterase (Ric)-8A and Gαi contribute to cytokinesis abscission by controlling vacuolar protein-sorting (Vps)34 activity.

Boularan C, Kamenyeva O, Cho H, Kehrl JH.

PLoS One. 2014 Jan 21;9(1):e86680. doi: 10.1371/journal.pone.0086680. eCollection 2014.

21.

Evaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound.

Guibal A, Boularan C, Bruce M, Vallin M, Pilleul F, Walter T, Scoazec JY, Boublay N, Dumortier J, Lefort T.

Eur Radiol. 2013 Apr;23(4):1138-49. doi: 10.1007/s00330-012-2692-y. Epub 2012 Nov 19.

PMID:
23160662
22.

Distinct functional outputs of PTEN signalling are controlled by dynamic association with β-arrestins.

Lima-Fernandes E, Enslen H, Camand E, Kotelevets L, Boularan C, Achour L, Benmerah A, Gibson LC, Baillie GS, Pitcher JA, Chastre E, Etienne-Manneville S, Marullo S, Scott MG.

EMBO J. 2011 Jun 3;30(13):2557-68. doi: 10.1038/emboj.2011.178.

23.

Meningococcus Hijacks a β2-adrenoceptor/β-Arrestin pathway to cross brain microvasculature endothelium.

Coureuil M, Lécuyer H, Scott MG, Boularan C, Enslen H, Soyer M, Mikaty G, Bourdoulous S, Nassif X, Marullo S.

Cell. 2010 Dec 23;143(7):1149-60. doi: 10.1016/j.cell.2010.11.035.

24.

Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47.

Bourougaa K, Naski N, Boularan C, Mlynarczyk C, Candeias MM, Marullo S, Fåhraeus R.

Mol Cell. 2010 Apr 9;38(1):78-88. doi: 10.1016/j.molcel.2010.01.041.

25.

Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha.

Claudinon J, Gonnord P, Beslard E, Marchetti M, Mitchell K, Boularan C, Johannes L, Eid P, Lamaze C.

J Biol Chem. 2009 Sep 4;284(36):24328-40. doi: 10.1074/jbc.M109.021915. Epub 2009 Jun 26.

26.

Targeting of beta-arrestin2 to the centrosome and primary cilium: role in cell proliferation control.

Molla-Herman A, Boularan C, Ghossoub R, Scott MG, Burtey A, Zarka M, Saunier S, Concordet JP, Marullo S, Benmerah A.

PLoS One. 2008;3(11):e3728. doi: 10.1371/journal.pone.0003728. Epub 2008 Nov 14.

27.

CXCR4-CCR5: a couple modulating T cell functions.

Contento RL, Molon B, Boularan C, Pozzan T, Manes S, Marullo S, Viola A.

Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10101-6. doi: 10.1073/pnas.0804286105. Epub 2008 Jul 15.

28.

beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53.

Boularan C, Scott MG, Bourougaa K, Bellal M, Esteve E, Thuret A, Benmerah A, Tramier M, Coppey-Moisan M, Labbé-Jullié C, Fåhraeus R, Marullo S.

Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18061-6. Epub 2007 Nov 5.

29.

Identification of differentially expressed genes in human varicose veins: involvement of matrix gla protein in extracellular matrix remodeling.

Cario-Toumaniantz C, Boularan C, Schurgers LJ, Heymann MF, Le Cunff M, Léger J, Loirand G, Pacaud P.

J Vasc Res. 2007;44(6):444-59. Epub 2007 Jul 20.

PMID:
17643059
30.

Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.

Chatenet D, Dubessy C, Boularan C, Scalbert E, Pfeiffer B, Renard P, Lihrmann I, Pacaud P, Tonon MC, Vaudry H, Leprince J.

J Med Chem. 2006 Nov 30;49(24):7234-8.

PMID:
17125276
31.

Structure-activity relationships and structural conformation of a novel urotensin II-related peptide.

Chatenet D, Dubessy C, Leprince J, Boularan C, Carlier L, Ségalas-Milazzo I, Guilhaudis L, Oulyadi H, Davoust D, Scalbert E, Pfeiffer B, Renard P, Tonon MC, Lihrmann I, Pacaud P, Vaudry H.

Peptides. 2004 Oct;25(10):1819-30.

PMID:
15476952

Supplemental Content

Loading ...
Support Center